AstraZeneca will be able to provide up to 200 million doses of its coronavirus vaccine by the end of 2020, and 700 million doses of the substance by the end of the first quarter of 2021. It was stated by the company's operations executive Pam Cheng, Reuters reported.
It was told that the company expected to send four million finished vaccine doses by the end of 2020, and another 40 million - by the end of the next year's first quarter.
According to Chang, these calculations are based on using two full doses, but the latest trial data suggests that higher efficacy is spotted when the initial shot is a half dose.
“If we go with a half dose you can imagine for the initial dose, we will be able to double the number of vaccinations here,” the statement said.
As we reported earlier, Moderna will charge governments between 25 and 37 dollars per dose of its Covid-19 vaccine candidate, depending on the amount ordered.
"Our vaccine, therefore, costs about the same as a flu shot, which is between 10 and 50 dollars," reads the message.